Bemis, Debra L <br/><br/>
Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression.  [electronic resource] 

 -  Nutrition and cancer  2005 
 - 202-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0163-5581 
<br/><br/><label>Standard No.: </label>10.1207/s15327914nc5202_10  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Caspase 3<br/>Caspases--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Curcumin--pharmacology<br/>Cyclooxygenase 1--drug effects<br/>Cyclooxygenase 2--drug effects<br/>Cyclooxygenase 2 Inhibitors--pharmacology<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Male<br/>Plant Extracts--pharmacology<br/>Prostatic Neoplasms--drug therapy